Motion Sickness Drugs Market, Availability of over-the-counter (OTC) drugs to boost market growth - Technavio
NEW YORK, Sept. 30, 2022 /PRNewswire/ -- Technavio's latest offering, the Motion Sickness Drugs Market report provides a detailed analysis of the competitive scenario and the market growth across various regions. The motion sickness drugs market value is anticipated to grow by USD 119.64 million, at a CAGR of 4.15% during the forecast period.
Market Driver
One of the reasons influencing the growth of the market for motion sickness medications is the accessibility of over-the-counter (OTC) medications. The first-line treatment for repressing and preventing motion sickness symptoms has been anticholinergics and antihistamines. Numerous antihistamines are sold over-the-counter (OTC) and are suitable for usage by young patients. Furthermore, rather than being used to treat motion sickness, these medications are primarily utilized to avoid its effects.
OTC drugs are described as pharmaceuticals that are distributed directly to patients or consumers without a doctor's prescription. The potential for patients to self-medicate for the treatment of minor sickness symptoms is made possible by the OTC availability of these medications, which also increases their accessibility and affordability. Request Free Sample Report.
Company Profiles
The motion sickness drugs market report includes information on the product launches, sustainability, and prospects of leading vendors including Aurobindo Pharma Ltd, Baxter International Inc., Caleb Pharmaceuticals Inc, Cipla Ltd., CVS Health Corp., DM Pharma, Dr Reddys Laboratories Ltd, GlaxoSmithKline Plc, Hylands, Johnson and Johnson, Lupin Ltd, Merck KGaA, Myungmoon Pharm Co. Ltd., Perrigo Co. Plc, Pfizer Inc., Prestige Consumer Healthcare Inc., Reliefband Technologies LLC, Viatris Inc., WellSpring Pharmaceutical Corp., and Zenomed Healthcare Pvt. Ltd. Buy Sample Report.
Competitive Analysis
The report includes competitive analysis, a proprietary tool to analyze and evaluate the position of companies based on their industry position score and market performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Market Segmentation
By Product
The anticholinergics market share for motion sickness medications will experience significant growth. An anticholinergic medication called scopolamine or hyoscine hydrobromide is used to treat motion sickness. A naturally occurring alkaloid called hyoscine binds to muscarinic receptors in a competitive manner, preventing the release of acetylcholine.
Because hyoscine is a lipophilic substance, it can cross the blood-brain barrier (BBB) and have an impact on both the central and parasympathetic nervous systems. In the near future, these variables will accelerate segment expansion.
By Geography
North America will account for 41% of market growth. The two biggest markets in North America for anti-motion sickness medications are the US and Canada. The market in this region will expand more slowly than the market in Asia. Over the projection period, rising consumer disposable income will support the expansion of the North American market for anti-motion sickness medications.
To know additional highlights and key points on various market segments and their impact in coming years, Download Free Sample Report.
North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution
North America at 41%
Key consumer countries
US, Canada, UK, Germany, and China
Competitive landscape
Leading companies, competitive strategies, consumer engagement scope
Companies profiled
Aurobindo Pharma Ltd, Baxter International Inc., Caleb Pharmaceuticals Inc, Cipla Ltd., CVS Health Corp., DM Pharma, Dr Reddys Laboratories Ltd, GlaxoSmithKline Plc, Hylands, Johnson and Johnson, Lupin Ltd, Merck KGaA, Myungmoon Pharm Co. Ltd., Perrigo Co. Plc, Pfizer Inc., Prestige Consumer Healthcare Inc., Reliefband Technologies LLC, Viatris Inc., WellSpring Pharmaceutical Corp., and Zenomed Healthcare Pvt. Ltd
Market Dynamics
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Table of Contents
1 Executive Summary
1.1 Market Overview
Exhibit 01: Executive Summary ? Chart on Market Overview
Exhibit 02: Executive Summary ? Data Table on Market Overview
Exhibit 03: Executive Summary ? Chart on Global Market Characteristics
Exhibit 04: Executive Summary ? Chart on Market by Geography
Exhibit 05: Executive Summary ? Chart on Market Segmentation by Product
Exhibit 06: Executive Summary ? Chart on Incremental Growth
Exhibit 07: Executive Summary ? Data Table on Incremental Growth
Exhibit 08: Executive Summary ? Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers ? Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers ? Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants ? Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes ? Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry ? Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Product
5.1 Market segments
Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
5.2 Comparison by Product
Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product
5.3 Anticholinergics - Market size and forecast 2021-2026
Exhibit 28: Chart on Anticholinergics - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Anticholinergics - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Anticholinergics - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Anticholinergics - Year-over-year growth 2021-2026 (%)
5.4 Antihistamines - Market size and forecast 2021-2026
Exhibit 32: Chart on Antihistamines - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Antihistamines - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Antihistamines - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Antihistamines - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Product
Exhibit 36: Market opportunity by Product ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share by geography 2021-2026 (%)
Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Canada - Market size and forecast 2021-2026
Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 Germany - Market size and forecast 2021-2026
Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity by geography
Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Baxter International Inc.
Exhibit 85: Baxter International Inc. - Overview
Exhibit 86: Baxter International Inc. - Business segments
Exhibit 87: Baxter International Inc. - Key news
Exhibit 88: Baxter International Inc. - Key offerings
Exhibit 89: Baxter International Inc. - Segment focus
10.4 Caleb Pharmaceuticals Inc
Exhibit 90: Caleb Pharmaceuticals Inc - Overview
Exhibit 91: Caleb Pharmaceuticals Inc - Product / Service
Exhibit 127: Validation techniques employed for market sizing
Exhibit 128: Information sources
11.5 List of abbreviations
Exhibit 129: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Yoneda Labs, the Y Combinator startup building a foundation model for chemists working in drug discovery, today announced it has raised $4 million in seed capital from Khosla Ventures, 500 Emerging Europe, 468 Capital, Fellows Fund, and Y Combinator....
People USA, funded by and in partnership with the New York State Office of Mental Health (OMH), is set to open 20 new scattered site housing units that will support individuals re-entering the community from New...
Harbor Point at Centerville, a Benchmark Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Massachusetts and the entire U.S. for the third straight year. In U.S. News & World Report's third annual...
Crescent Point at Niantic, a Benchmark assisted living and Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Connecticut and the entire U.S. for the third straight year. In U.S. News & World...
Houston, we don't have a foot care problem ? now that Modern Foot & Ankle has moved into the Lone Star State. The podiatric group originated in Florida and has a strong presence in Tampa, Orlando, and Palm Beach. But with its recent acquisition of a...
Gestalt Diagnostics has added healthcare industry expert, Dr. J. Mark Tuthill, to serve on Gestalt's Advisory Board. He will be joining Gestalt's distinguished Advisory Board of pathologists contributing to oversight and active input of development...